PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
19-Mar-2026 Bio Sourcing and Tiny Cargo join forces to develop oral delivery therapies of monoclonal antibodies using goat milk exosomes Bio Sourcing
19-Mar-2026 Atrogi announces first subjects dosed in human trial for lead candidate ATR-258 Atrogi
19-Mar-2026 Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics Basecamp Research
19-Mar-2026 Green Elephant Biotech Introduces Archimedes® One, the First Dynamic Adherent Bioreactor for Cell Therapy Manufacturing Green Elephant Biotech
19-Mar-2026 Results from EMBRACE Phase 2a study of emapalumab in interferon-gamma–driven sepsis presented at ISICEM Sobi
19-Mar-2026 Genoskin Showcases HypoSkin® Ex Vivo Platform at SOT Annual Meeting Genoskin
19-Mar-2026 Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference ACCESS Newswire
19-Mar-2026 IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 ACCESS Newswire
19-Mar-2026 Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results Businesswire
19-Mar-2026 LIEBHERR expands UK laboratory portfolio with seven high precision countertop and fully integrated under bench models LIEBHERR
19-Mar-2026 Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities ACCESS Newswire
19-Mar-2026 Cenevo’s Labguru Drives Digital Lab Transformation for Pace® Life Sciences Cenevo
19-Mar-2026 AlzeCure presents new preclinical data with NeuroRestore ACD856 at the Alzheimer's Conference AD/PD AlzeCure
19-Mar-2026 Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 Finance Contract Newron
19-Mar-2026 BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair BOOST Pharma
19-Mar-2026 Oncoinvent secures new patent expanding protection for Radspherin® Oncoinvent
19-Mar-2026 Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS Businesswire
19-Mar-2026 Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share ACCESS Newswire
19-Mar-2026 Aptevo to Participate in March 2026 Conferences ACCESS Newswire
19-Mar-2026 Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion ACCESS Newswire